IEEE Pulse最新文献

筛选
英文 中文
A Substance Use Disorder Virtual Treatment and Research Platform: A Proof of Concept. 物质使用障碍虚拟治疗和研究平台:概念验证。
IF 0.2 4区 医学
IEEE Pulse Pub Date : 2025-11-01 DOI: 10.1109/MPULS.2025.3640837
Tyler S Oesterle, Nicholas L Bormann, Mark A Lifson, Katina Michael
{"title":"A Substance Use Disorder Virtual Treatment and Research Platform: A Proof of Concept.","authors":"Tyler S Oesterle, Nicholas L Bormann, Mark A Lifson, Katina Michael","doi":"10.1109/MPULS.2025.3640837","DOIUrl":"10.1109/MPULS.2025.3640837","url":null,"abstract":"<p><p>Substance use disorders (SUDs) remain a major public health challenge, exacerbated by limited access to care, low treatment engagement, and the disruption of services during the COVID-19 pandemic. Mobile phone applications (MPAs) offer a scalable mechanism for delivering behavioral health interventions; however, existing apps suffer from low engagement, limited methodological rigor, and inflexibility for research and clinical adaptation. This article presents Senyo, a proof-of-concept virtual treatment and research platform designed to support individuals with SUD while enabling systematic evaluation of mobile therapeutic strategies. The platform integrates an extensible mobile application with secure web-based portals for providers and researchers, enabling the delivery of asynchronous cognitive behavioral therapy (CBT) content, activity-based goals, and a token-economy-based contingency management (CM) reward system. Social reinforcement is incorporated through clinician messaging and tele-support, enhancing engagement and adherence. The researcher interface allows for real-time modification of modules, surveys, goals, and incentives without additional app development, facilitating blinded, randomized, and comparative studies within a single platform. The system is designed to be HIPAA compliant and aligned with emerging regulatory frameworks for software as a medical device. This work demonstrates the feasibility of a flexible, research-ready digital therapeutic infrastructure and outlines its potential to improve engagement, support evidence-based care, and advance rigorous evaluation of mobile interventions for SUD and related behavioral health conditions.</p>","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":"16 6","pages":"53-63"},"PeriodicalIF":0.2,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147370573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liquid and Synthetic Biopsies Are Poised to Rewrite Cancer Care. 液体和合成活检将改写癌症治疗。
IF 0.2 4区 医学
IEEE Pulse Pub Date : 2025-11-01 DOI: 10.1109/MPULS.2025.3640838
Mary Bates
{"title":"Liquid and Synthetic Biopsies Are Poised to Rewrite Cancer Care.","authors":"Mary Bates","doi":"10.1109/MPULS.2025.3640838","DOIUrl":"10.1109/MPULS.2025.3640838","url":null,"abstract":"<p><p>Liquid biopsy is an innovative and promising alternative to traditional tissue biopsy for detecting and monitoring cancer. It involves analyzing cancer-related biomarkers, such as genetic material shed from tumors, in the blood or other body fluids. Synthetic biopsy is a related approach in which cancer cells are forced to produce biomarkers that reveal their presence. Liquid biopsy tests have been used for years to identify actionable genetic mutations that respond to certain targeted cancer therapies. Researchers are now working to integrate liquid and synthetic biopsies into other facets of cancer care, including screening and early detection, tracking disease progression, monitoring therapeutic response, and assessing minimal residual disease (MRD).</p>","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":"16 6","pages":"22-25"},"PeriodicalIF":0.2,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147370586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Engineering Better Cancer Care in Low and Middle-Income Countries. 在低收入和中等收入国家设计更好的癌症治疗。
IF 0.2 4区 医学
IEEE Pulse Pub Date : 2025-11-01 DOI: 10.1109/MPULS.2025.3640849
Muhammad Hamid Zaman
{"title":"Engineering Better Cancer Care in Low and Middle-Income Countries.","authors":"Muhammad Hamid Zaman","doi":"10.1109/MPULS.2025.3640849","DOIUrl":"10.1109/MPULS.2025.3640849","url":null,"abstract":"<p><p>Cancer deaths are rising in underserved regions, requiring context-specific research, equitable care, and accessible engineering solutions.</p>","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":"16 6","pages":"50-52"},"PeriodicalIF":0.2,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147391392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lighting the Way to Treat Advanced Stomach Cancer. 点亮晚期胃癌的治疗之路。
IF 0.2 4区 医学
IEEE Pulse Pub Date : 2025-11-01 DOI: 10.1109/MPULS.2025.3640842
Kristina Grifantini
{"title":"Lighting the Way to Treat Advanced Stomach Cancer.","authors":"Kristina Grifantini","doi":"10.1109/MPULS.2025.3640842","DOIUrl":"10.1109/MPULS.2025.3640842","url":null,"abstract":"<p><p>Advanced stomach cancer is incredibly difficult to treat, as tumor cells can hide throughout the abdomen, evading surgery and chemotherapy. Current treatments often cause severe side effects and are not fully effective. Researchers at the University of Texas are developing a new therapy that combines engineered proteins with near-infrared light to precisely target cancer cells, offering a promising, less toxic approach for stomach cancer.</p>","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":"16 6","pages":"26-29"},"PeriodicalIF":0.2,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147370522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Industry Corner Live With AngioDynamics CEO Jim Clemmer. 与血管动力学首席执行官吉姆克莱默的行业角现场直播。
IF 0.2 4区 医学
IEEE Pulse Pub Date : 2025-11-01 DOI: 10.1109/MPULS.2025.3640869
Chad Andresen
{"title":"Industry Corner Live With AngioDynamics CEO Jim Clemmer.","authors":"Chad Andresen","doi":"10.1109/MPULS.2025.3640869","DOIUrl":"10.1109/MPULS.2025.3640869","url":null,"abstract":"<p><p>Jim Clemmer, CEO of AngioDynamics, shares how he transformed the company into a science-driven innovator focused on cancer and cardiovascular disease through bold portfolio changes, deep physician engagement, and a strong market access strategy. His insights highlight the importance of agility, data-driven credibility, and aligning reimbursement early to bring groundbreaking MedTech technologies to market.</p>","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":"16 6","pages":"71-74"},"PeriodicalIF":0.2,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147370576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Results in a Week to a Month. 结果在一个星期到一个月。
IF 0.2 4区 医学
IEEE Pulse Pub Date : 2025-11-01 DOI: 10.1109/MPULS.2025.3640857
Leslie Mertz
{"title":"Results in a Week to a Month.","authors":"Leslie Mertz","doi":"10.1109/MPULS.2025.3640857","DOIUrl":"10.1109/MPULS.2025.3640857","url":null,"abstract":"<p><p>Patient-grown microtumors on a chip let researchers test therapies in days and may even reveal which cancers are poised to spread.</p>","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":"16 6","pages":"8-14"},"PeriodicalIF":0.2,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147370542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Detecting Role Impersonation in AI-Generated Clinical Oncology Text Using Knowledge Graphs. 利用知识图谱检测人工智能生成的临床肿瘤学文本中的角色模拟。
IF 0.2 4区 医学
IEEE Pulse Pub Date : 2025-11-01 DOI: 10.1109/MPULS.2025.3640870
Amar Banerjee, Arnab Roy
{"title":"Detecting Role Impersonation in AI-Generated Clinical Oncology Text Using Knowledge Graphs.","authors":"Amar Banerjee, Arnab Roy","doi":"10.1109/MPULS.2025.3640870","DOIUrl":"10.1109/MPULS.2025.3640870","url":null,"abstract":"<p><p>Large language models (LLMs) are increasingly used in oncology for drafting radiology reports, pathology summaries, tumor-board notes, and clinical trial documentation. While their fluency and contextual adaptability enable workflow acceleration, such linguistic proficiency can conceal a critical risk: impersonation of oncologists or cancer researchers by mimicking professional tone without adhering to oncologic reasoning or procedural logic. This work presents a framework for detecting domain-level role impersonation in AI-generated oncology communication. Central to our method is the role impersonation index (RII), a composite metric that quantifies semantic fidelity and procedural coherence (PC) by aligning generated content with expert knowledge encoded in structured ontologies such as SNOMED CT, UMLS, and cancer-specific resources, including NCIt and OncoTree. Evaluated on 4,800 clinical oncology notes, balanced between human and AI authorship, our framework identifies inconsistencies in tumor terminology, diagnostic staging, biomarker logic, and therapeutic sequencing without relying on superficial linguistic cues, achieving an $F1$ -score of 94% and an AUROC of 0.96. By embedding cancer-domain semantics and established clinical workflows into the detection process, the proposed approach provides a principled safeguard for the trustworthy integration of generative AI in oncology practice. To our knowledge, this is the first framework that integrates knowledge-graph alignment with procedural logic scoring to detect role impersonation in cancer-related clinical documentation.</p>","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":"16 6","pages":"75-86"},"PeriodicalIF":0.2,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147370507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Innovations in Cancer: Laser Light, AI, and Micromaterials. 癌症的创新:激光、人工智能和微材料。
IF 0.2 4区 医学
IEEE Pulse Pub Date : 2025-11-01 DOI: 10.1109/MPULS.2025.3640845
Jim Banks
{"title":"Innovations in Cancer: Laser Light, AI, and Micromaterials.","authors":"Jim Banks","doi":"10.1109/MPULS.2025.3640845","DOIUrl":"10.1109/MPULS.2025.3640845","url":null,"abstract":"<p><p>Quality of life should be the top priority for patients with late-stage cancer, but standard chemotherapy treatments often bring great physical and emotional hardship in their final months. A new platform for injectable microparticles that combine thermal ablation and targeted chemotherapy at the tumor site may help is helping to change that, as well as opening up a new approach to treat the realm of therapeutic potential for cancer treatment at earlier stages. Jim Banks looks at the pioneering work of esteemed bioengineer Dr. Ana Jaklenec, principal investigator at the David H. Koch Institute for Integrative Cancer Research at MIT.</p>","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":"16 6","pages":"5-7"},"PeriodicalIF":0.2,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147370584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Edge AI Is Reimagining What Home Cancer Care Can Be. 边缘人工智能正在重塑家庭癌症护理的方式。
IF 0.2 4区 医学
IEEE Pulse Pub Date : 2025-11-01 DOI: 10.1109/MPULS.2025.3640852
Nathan Allen-Zimmerer
{"title":"Edge AI Is Reimagining What Home Cancer Care Can Be.","authors":"Nathan Allen-Zimmerer","doi":"10.1109/MPULS.2025.3640852","DOIUrl":"10.1109/MPULS.2025.3640852","url":null,"abstract":"<p><p>Home-based cancer care is expanding through telemedicine, yet patients often face long intervals between clinical visits with limited symptom surveillance. Edge artificial intelligence (Edge-AI) enables continuous physiologic monitoring using on-device analysis of wearable and sensor data, reducing reliance on cloud transmission and preserving privacy. Early clinical studies report reduced emergency department utilization, though survival outcomes remain unproven. Key challenges include clinical integration, alert workflow design, data governance, and equity in access. When responsibly implemented, Edge-AI may enhance timely intervention, protect patient autonomy, and support scalable home oncology care.</p>","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":"16 6","pages":"35-38"},"PeriodicalIF":0.2,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147370520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bubbling Tumors Into Oblivion. 冒泡肿瘤被遗忘。
IF 0.2 4区 医学
IEEE Pulse Pub Date : 2025-11-01 DOI: 10.1109/MPULS.2025.3640860
Janet Rae-Dupree
{"title":"Bubbling Tumors Into Oblivion.","authors":"Janet Rae-Dupree","doi":"10.1109/MPULS.2025.3640860","DOIUrl":"10.1109/MPULS.2025.3640860","url":null,"abstract":"<p><p>An ultrasound treatment called histotripsy is opening new ways of thinking about cancer intervention. Using millimeter-sized points of hyper-focused ultrasound waves delivered noninvasively to liquefy tumors, histotripsy allows the body to reabsorb acellular debris after treatment. Currently approved by the FDA only for use in liver tumors, histotripsy is expected to expand broadly. While other treatments, including surgeries, may require stopping chemotherapy, histotripsy can be done simultaneously with systemic therapies. Because it is noninvasive, patients who otherwise may not be candidates for surgery can have their tumors treated. Histotripsy marks a turning point in cancer care and, down the road, potentially an array of noncancer issues. Unlike other technologies to remove unwanted body tissue, ablation with histotripsy involves no heat or irradiation and doesn't damage healthy tissue surrounding a tumor. Intriguingly, researchers are also discovering that its aftereffects may stimulate the immune system, prompting regression of untreated tumors throughout the body. They are currently working on how to combine its ultrasonic pulses with immunotherapy to help the body sic its own T-cells on recalcitrant tumors.</p>","PeriodicalId":49065,"journal":{"name":"IEEE Pulse","volume":"16 6","pages":"15-21"},"PeriodicalIF":0.2,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147370500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书